Related Experiment Video
Updated: Jun 13, 2026

Revealing the Ferroptotic Phenotype of Medulloblastoma
Published on: March 15, 2024
OxLDL-induced ferroptosis and pyroptosis in atherosclerosis: a mini review
Shaozhi Liu1, Yuxia Wu2, Lei Chen1
1Department of Pharmacy, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Abstract:
Oxidized low-density lipoprotein (oxLDL) is a central driver of inflammatory responses in atherosclerosis and triggers multiple forms of regulated cell death beyond classical apoptosis. Ferroptosis, characterized by iron-dependent lipid peroxidation (LPO), and pyroptosis, mediated by inflammasome-activated gasdermin D (GSDMD) pore formation, have emerged as critical contributors to plaque progression and instability. Recent evidence highlights a significant crosstalk between these two death modalities: the N-terminal fragment of GSDMD targets mitochondrial membranes to promote LPO, while ferroptotic byproducts-including oxidized phospholipids and 4-hydroxynonenal-activate the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome. This bidirectional interplay establishes a positive feedback loop that amplifies vascular inflammation. This review summarizes the molecular mechanisms underlying oxLDL-induced ferroptosis and pyroptosis, emphasizes their interconnected regulatory networks, and discusses therapeutic strategies targeting this cell death axis. Understanding this integrated cell death network may provide new insights for resolving residual inflammatory risk in atherosclerotic cardiovascular disease.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis III: Management
Inflammation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests